Physician profile
Andrew L James
NPI 1871586321
$25,716.48
in general payments reported to CMS, 2019-2025
9 companies · $1,893 in 2025
The $1,893 reported for 2025 was more than what 98% of Medical-Surgical (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,440 · 2022: $7,682 · 2023: $5,641 · 2024: $7,061 · 2025: $1,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,494 · Travel and Lodging: $4,111 · Education: $2,418 · Food and Beverage: $1,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,494.17 |
| Travel and Lodging | $4,110.59 |
| Education | $2,418.01 |
| Food and Beverage | $1,571.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22,565.35 | 2021-2025 | Evenity, Prolia, Prolia |
| Radius Health, INC. | $2,918.74 | 2021-2025 | Tymlos |
| Alvogen INC | $72.61 | 2024-2025 | Teriparatide |
| Novo Nordisk INC | $52.04 | 2021-2024 | Wegovy |
| Kyowa Kirin, INC. | $35.55 | 2023-2024 | Crysvita |
| Impulse Dynamics (USA) INC. | $20.88 | 2021 | |
| Ascend Therapeutics US, LLC | $20.46 | 2021 | |
| Integra Lifesciences Corporation | $16.23 | 2023 | Tcc-Ez |
| Lilly USA, LLC | $14.62 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.